Zobrazeno 1 - 10
of 361
pro vyhledávání: '"Bonnie Ky"'
Autor:
Leila Mabudian, Kerry Reding, Ralph B. D’Agostino, Emily M. Heiston, Moriah P. Bellissimo, Kristine Olson, William O. Ntim, Heidi D. Klepin, Emily V. Dressler, Tonya Moore, Jennifer H. Jordan, Nathaniel S. O’Connell, Amy Ladd, Kathryn E. Weaver, Bonnie Ky, Lynne I. Wagner, Mary Helen Hackney, Glenn J. Lesser, W Gregory Hundley, The UPBEAT Study Team
Publikováno v:
Cardio-Oncology, Vol 10, Iss 1, Pp 1-8 (2024)
Abstract Background To understand how body composition in those with elevated body mass index impacts left ventricular function decline during cancer treatment, we determined the association between baseline body mass index (BMI), intra-abdominal adi
Externí odkaz:
https://doaj.org/article/a72660f3ecad44b988f5b480364572d9
Autor:
Kasey J. Leger, Michael J. Absalon, Biniyam G. Demissei, Amanda M. Smith, Robert B. Gerbing, Todd A. Alonzo, Hari K. Narayan, Betsy A. Hirsch, Jessica A. Pollard, Bassem I. Razzouk, Kelly D. Getz, Richard Aplenc, E. Anders Kolb, Bonnie Ky, Todd M. Cooper
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
IntroductionAnthracyclines are effective in treating acute myeloid leukemia (AML) but limited by cardiotoxicity. CPX-351, a liposomal daunorubicin and cytarabine, may provide therapeutic benefit with less cardiotoxicity. Acute changes in left ventric
Externí odkaz:
https://doaj.org/article/4f7d5c7ff98a44ee954f1d19f9442a1c
Autor:
Kasey J. Leger, Nora Robison, Hari K. Narayan, Amanda M. Smith, Tenaadam Tsega, Jade Chung, Amber Daniels, Zhen Chen, Virginia Englefield, Biniyam G. Demissei, Benedicte Lefebvre, Gemma Morrow, Ilona Dizon, Robert B. Gerbing, Reena Pabari, Kelly D. Getz, Richard Aplenc, Jessica A. Pollard, Eric J. Chow, W. H. Wilson Tang, William L. Border, Ritu Sachdeva, Todd A. Alonzo, E. Anders Kolb, Todd M. Cooper, Bonnie Ky
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundPediatric acute myeloid leukemia (AML) therapy is associated with substantial short- and long-term treatment-related cardiotoxicity mainly due to high-dose anthracycline exposure. Early left ventricular systolic dysfunction (LVSD) compromis
Externí odkaz:
https://doaj.org/article/b99055bf1d704eadae2a445572632039
Autor:
Andrija Matetic, Bonnie Ky, Eric H. Yang, Phyo K. Myint, Muhammad Rashid, Shelley Zieroth, Timir K. Paul, Ayman Elbadawi, Mamas A. Mamas
Publikováno v:
Cancer Medicine, Vol 12, Iss 5, Pp 5471-5484 (2023)
Abstract Background Pericardiocentesis is undertaken in patients with cancer for diagnostic and therapeutic purposes. However, there are limited data on the frequency, characteristics and mortality of patients with different cancers undergoing perica
Externí odkaz:
https://doaj.org/article/9d0cbb083b0e4ef4b52c3d713e64dba1
Autor:
Michael G. Fradley, Nam H. K. Nguyen, David Madnick, Yiqing Chen, Angela DeMichele, Igor Makhlin, Susan Dent, Benedicte Lefebvre, Joseph Carver, Jenica N. Upshaw, David DeRemer, Bonnie Ky, Avirup Guha, Yan Gong
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 12 (2023)
Background Cyclin‐dependent kinase (CDK) 4 and 6 inhibitors have significantly improved survival in patients with hormone receptor–positive metastatic breast cancer. There are few data regarding the epidemiology of cardiovascular adverse events (
Externí odkaz:
https://doaj.org/article/f73097a8c1484ebdafe65151a6a2f245
Autor:
Nikhil Yegya-Raman, Timothy P. Kegelman, Sang Ho Lee, Michael J. Kallan, Kristine N. Kim, Jyotsna Natarajan, Matthew P. Deek, Wei Zou, Shannon E. O'Reilly, Zheng Zhang, William Levin, Keith Cengel, Gary Kao, Roger B. Cohen, Lova L. Sun, Corey J. Langer, Charu Aggarwal, Aditi P. Singh, Rupal O'Quinn, Bonnie Ky, Aditya Apte, Joseph Deasy, Ying Xiao, Abigail T. Berman, Salma K. Jabbour, Steven J. Feigenberg
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 39, Iss , Pp 100581- (2023)
Background and purpose: Prior studies have examined associations of cardiovascular substructure dose with overall survival (OS) or cardiac events after chemoradiotherapy (CRT) for non-small cell lung cancer (NSCLC). Herein, we investigate an alternat
Externí odkaz:
https://doaj.org/article/2c6ebd01b13d4332921dd0185ea6507f
Autor:
Kathleen M. Sturgeon, Amanda M. Smith, Elizabeth H. Federici, Namratha Kodali, Renée Kessler, Edward Wyluda, Leah V. Cream, Bonnie Ky, Kathryn H. Schmitz
Publikováno v:
BMC Sports Science, Medicine and Rehabilitation, Vol 14, Iss 1, Pp 1-11 (2022)
Abstract Purpose To evaluate the feasibility of a home-based moderate-to-vigorous intensity, phased (introduction, intermediate, maintenance), exercise prescription in breast cancer patients receiving cardiotoxic neoadjuvant chemotherapy. Methods Nin
Externí odkaz:
https://doaj.org/article/ab7e5c08172148f598f9d674ccac177b
Autor:
Jae Won Jung, Matthew M. Mille, Bonnie Ky, Walter Kenworthy, Choonik Lee, Yeon Soo Yeom, Aaron Kwag, Walter Bosch, Shannon MacDonald, Oren Cahlon, Justin E. Bekelman, Choonsik Lee
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 19, Iss , Pp 138-144 (2021)
Background and purpose: Quantifying radiation dose to cardiac substructures is important for research on the etiology and prevention of complications following radiotherapy; however, segmentation of substructures is challenging. In this study we demo
Externí odkaz:
https://doaj.org/article/147ccc395194418b9200d1177a23db5c
Autor:
Srilakshmi Vallabhaneni, Yue Wang, Ying Zhang, Amanda Smith, Wei Zou, Steven Feigenberg, John Plastaras, Gary Freedman, Walter R. T. Witschey, Bonnie Ky, Yuchi Han
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundChest radiation therapy (RT) is known to be associated with cardiotoxicity. However, the changes in myocardial tissue characterization with radiation-induced cardiotoxicity are not well-understood.ObjectivesThis study sought to assess the c
Externí odkaz:
https://doaj.org/article/6dc2632192ab4d8aa781f96f9c2f09d4
Publikováno v:
Cardio-Oncology, Vol 7, Iss 1, Pp 1-13 (2021)
Abstract Background Breast cancer is the most common female cancer worldwide. Effective therapies including doxorubicin and trastuzumab have improved survival, but are associated with a substantial risk of cardiovascular disease. Mechanisms underlyin
Externí odkaz:
https://doaj.org/article/c438f4ad1cb2412487e4b6afafff1839